巴克莱下调Kenvue目标股价至每股22美元

华尔街洞察
Jul 16

巴克莱分析师日前将消费品巨头Kenvue(NYSE:KVUE)的目标股价从每股23美元调降至22美元。此次调整反映了该机构对这家从强生分拆的消费健康公司的最新估值判断。

市场分析显示,此次目标价调整发生在7月15日美股交易时段。尽管具体调整依据未在公开信息中详述,但券商机构对目标价的修订往往基于企业财务表现、行业竞争格局及宏观经济预期等综合因素的重新评估。

作为全球最大的纯消费健康上市公司,Kenvue旗下拥有李施德林漱口水、邦迪创可贴等知名品牌,其股价走势受到投资者对必需消费品板块估值逻辑变化的密切关注。此次巴克莱的估值调整,将为市场参与者提供新的价值参考坐标。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10